Evidence map›Paper›PMID 21146962›Full record

ArticleJournal of dermatological science2011

Optimization of filaggrin expression and processing in cultured rat keratinocytes.

Sudeshna M Chatterjea, Katheryn A Resing, William Old, Wilas Nirunsuksiri, Philip Fleckman

Abstract read
In one paragraph

Article in Journal of dermatological science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sudeshna M ChatterjeaDepartment of Chemistry & Biochemistry, University of Colorado at Boulder, Boulder, CO 80309, USA.
Katheryn A Resing
William Old
Wilas Nirunsuksiri
Philip Fleckman
University of Colorado Boulder · USUniversity of Washington · US

Funding

STRUCTURAL PROTEINS IN DISORDERS OF KERATINIZATIONP01AR021557 · NIAMS · UNIVERSITY OF WASHINGTON · PI FLECKMAN, PHILIP H · 1986 to 2001
$2.8M
INTERDISCIPLINARY BASIC RESEARCH IN DERMATOLOGYP01AM021557 · AM · UNIVERSITY OF WASHINGTON · PI ODLAND, GEORGE F. · 1985 to 1985
–
PROTEIN PROCESSING IN EPIDERMAL DIFFERENTIATIONR01AR043768 · NIAMS · UNIVERSITY OF COLORADO AT BOULDER · PI RESING, KATHERYN A · 1996 to 1999
–
KERATOHYALIN IN KERATINIZATION OF ORAL MUCOSAR37DE004660 · NIDCR · UNIVERSITY OF WASHINGTON · PI DALE-CRUNK, BEVERLY A · 1987 to 1996
–
NIADDK NIH HHS P01 AM-21557NIADDK NIH HHS P01-AM21557NIAMS NIH HHS AR43768NIAMS NIH HHS P01 AR021557NIAMS NIH HHS R01 AR043768NIDCR NIH HHS R37 DE004660NIDCR NIH HHS R37 DE-04660
6 · The paper itself

Abstract

backgroundIn normal mammalian epidermis, cell division occurs primarily in the basal layer where cells are attached to the basement membrane. Upon release from the basement membrane, these basal cells stop dividing and begin to differentiate and stratify producing cornified cells expressing differentiation markers, including the keratin bundling protein filaggrin, and cornified envelope proteins. Little is understood about the regulatory mechanisms of these processes. A rat epidermal keratinocyte cell line synthesizing and processing profilaggrin at confluence in a synchronous manner for 4-5 days provides a useful culture model for epidermal differentiation. Profilaggrin expression in this cell line however decreases with passaging, and its processing involves extensive nonspecific proteolysis.

objectiveOur objective was to identify culture conditions that effect the decrease in profilaggrin expression with passaging and nonspecific proteolysis of profilaggrin in order to study epidermal differentiation more closely.

methodThe large amount of nonspecific proteolysis suggested autophagocytosis. To test this, cells were cultured in the presence of 3-methyladenine (3-MA). Two known gradients in epidermis are decreasing serum components and increasing calcium concentrations in the upper cell layers. To determine whether these gradients effected processing, cells were cultured in serum/DMEM or in serum-free KGM and under varying external calcium concentrations. Cells were also cultured in presence of aminoguanidine in an attempt to maintain profilaggrin expression with passaging.

resultsProfilaggrin expression was enhanced in the presence of 3-MA, with optimum around 6mM. In the absence of aminoguanidine, profilaggrin expression decreased as a function of increasing passage number; in its presence, profilaggrin expression remained high in some, but not in all of the independently maintained cell lines. Thus, culturing in aminoguanidine was necessary, but not sufficient, for sustained ability to express profilaggrin at confluence. Production of filaggrin from profilaggrin was maximized in a serum-free medium with [Ca(2+)] at 5mM. Filaggrin associates with phospholipid vesicles in vitro forming aggregates similar to those seen in vivo, suggesting that filaggrin release induces vesicular aggregation and autophagocytosis.

conclusionWe have used a keratinocyte cell line that synthesizes and processes profilaggrin after confluence as a culture model to study epidermal differentiation. In this system profilaggrin processing must be preceded by inhibition of autophagosome formation and/or modulation of vesicular trafficking, and these processes are regulated by epidermal calcium and serum factor gradients.

Indexed as

AdenineAnimalsAutophagyCalciumCell DifferentiationCells, CulturedCellular SenescenceCulture TechniquesFilaggrin ProteinsGuanidinesIntermediate Filament ProteinsKeratinocytesRats3-methyladenineAdenineCalciumFilaggrin ProteinsGuanidinesIntermediate Filament Proteinspimagedine

Identifiers

PMID21146962
PMCPMC3031422
OpenAlexW2120997062

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.